Back
Sep 29
Poster Q & A
PQA 03 - Central Nervous System, Professional Development/Medical Education
Presentations
-
08:00am - 09:00am PT
A Bibliometric Analysis of the 100 Most Influential Papers in Radiation Oncology: Mapping a Decade of Scientific Progress
Speaker: Haseeb Choudhry, - University of Connecticut, Mansfield -
08:00am - 09:00am PT
A Five-Year Update of a Scoping Review of Mentorship Initiatives in Radiation Oncology
Speaker: Wilmene Hercule, - Rush University Medical Center, Chicago -
08:00am - 09:00am PT
-
08:00am - 09:00am PT
A Model for a Community Radiation Oncology Cancer Center Providing a Comprehensive Spectrum of Radiopharmaceutical Treatment
Speaker: Vivek Mehta, MD - Swedish Cancer Institute, Seattle -
08:00am - 09:00am PT
-
08:00am - 09:00am PT
A Multi-Institutional Prospective Observational Study of Linear Accelerator-Based Single-Isocenter Stereotactic Irradiation for Multiple Brain Metastases
Speaker: Megumi Uto, MD, PhD - Kyoto University Graduate School of Medicine, Kyoto -
08:00am - 09:00am PT
A Patch-Based Deep Learning Approach for Brain Metastases Segmentation: Balanced Sampling Strategy for Class Imbalance
Speaker: Heejoo Ko, MD, BS - College of Medicine, The Catholic University of Korea, Hwasung -
08:00am - 09:00am PT
A Real-World Analysis of Clinical Prognostic Factors Influencing Survival in Patients with High-Grade Glioma (HGG) Receiving Radiotherapy (RT)
Speaker: Cole Friedes, MD - University of Pennsylvania, Philadelphia -
08:00am - 09:00am PT
A Rising Tide: Trends and Predictors of Resident Research Productivity in Canadian Radiation Oncology
Speaker: Enxhi Kotrri, MD - Western University, London -
08:00am - 09:00am PT
A Single-Center Randomized Trial Comparing the Outcomes of Hypofractionated Stereotactic Radiotherapy in Different Regimens for Large Brain Metastases
Speaker: Elena Vetlova, MD - Burdenko Neurosurgery Institute, Moscow -
08:00am - 09:00am PT
A Twelve-Gene Prognostic Signature Predicts Survival and Immune Correlates in Radiotherapy-Treated Low-Grade Glioma
Speaker: Lifei Zhu, MD, PhD - Southeast Health, Dothan -
08:00am - 09:00am PT
Additional Brain Metastases Identified on SRS Treatment MRI: A Missed Opportunity?
Speaker: Phillip Jenkins, DO, MS - Detroit Medical Center/Wayne State University, Detroit -
08:00am - 09:00am PT
Analysis of the Safety Cohort of a Phase II Study of Preoperative Stereotactic Radiosurgery for Brain Metastases
Speaker: Lucinda Burke, MBBS - Radiation Oncology Network, Western Sydney Local Health District, Sydney -
08:00am - 09:00am PT
Application of Whole Brain Radiation Therapy in Leptomeningeal Metastatic NSCLC Patients in Target Therapy Age: A Retrospective Cohort Study on Dose-Fractionation Regimens and Prognostic Factors
Speaker: Shoaib Bashir, MD, PhD - Guangdong Sanjiu Brain Hospital, Guangzhou -
08:00am - 09:00am PT
Assessing FLASH Effect on Late-Responding Organ Toxicity in Hypofractionation Using a Rat Spinal Cord Model
Speaker: Banghao Zhou, MS - UT Southwestern Medical Center, Dallas -
08:00am - 09:00am PT
-
08:00am - 09:00am PT
Assessment of Subventricular Zone Irradiation in Glioblastoma Patients
Speaker: Laya Pillai, - The Gujarat Cancer and Research Institute, Ahmedabad -
08:00am - 09:00am PT
Association of Treatment Modality with Net Survival and Cause-Specific Excess Mortality in Craniopharyngioma: A Population-Based Analysis in the Modern Radiotherapy Era
Speaker: Zi Du, - Chinese Academy of Medical Sciences Cancer Institute and Hospital: Cancer Hospital Chinese Academy of Medical Sciences, Beijing -
08:00am - 09:00am PT
Brain Metastases from Soft Tissue Sarcoma
Speaker: Srivatsa Vedala, - MD Anderson Cancer Center, Houston -
08:00am - 09:00am PT
Brain Protein I3 (BRI3) Predicts Disease Fate in Glioblastoma
Speaker: Ifeanyichukwu Ogobuiro, MD, MS - University of Miami Sylvester Comprehensive Cancer Center, Miami -
08:00am - 09:00am PT
-
08:00am - 09:00am PT
Change in Cognitive Function in Patients with Brain Metastasis Treated with Stereotactic Radiosurgery Quantified by Hippocampal Dose
Speaker: Peyton Kimmel, - Temple/St. Lukes School of Medicine, Bethlehem -
08:00am - 09:00am PT
Clinical and Dosimetric Predictors of Severe Radiation-Induced Lymphopenia in Patients with Newly Diagnosed IDH-Wildtype High Grade Glioma Undergoing Adjuvant Radiotherapy
Speaker: Melanie Berger, MD - Hospital of the University of Pennsylvania, Philadelphia -
08:00am - 09:00am PT
Clinical Efficacy and Safety Evaluation of Moderately Hypofractionated Radiotherapy with Simultaneous Integrated Boost (MHRT-SIB) for Spinal Metastases: A Retrospective Study
Speaker: Ping Jiang, MD - Peking University 3rd Hospital, Beijing -
08:00am - 09:00am PT
Clinical Feasibility and Prospective Developments of Fan Beam CT-Guided All-in-One Emergency Radiotherapy
Speaker: Junjie Wang, PhD - Department of Radiation Oncology, Peking University Third Hospital, Beijing -
08:00am - 09:00am PT
Clinical Target Volume Delineation in Stereotactic Radiosurgery for Sacral Spine Metastases
Speaker: Joseph Abi Jaoude, MD - Stanford University, Stanford -
08:00am - 09:00am PT
Clinical Target Volumes for Glioma with Automatic Integration of Tumor Infiltration Pathways
Speaker: Gregory Buti, PhD - Massachusetts General Hospital, Winchester -
08:00am - 09:00am PT
Comorbidity Burden and Radiotherapy in Elderly Glioblastoma Patients
Speaker: Sophia Leiss, - Department of Radiation Oncology, TUM University Hospital, Munich -
08:00am - 09:00am PT
Comparative Evaluation of Tile Estimation Workflows for STaRT Pre-Planning in Patients with Recurrent Brain Metastasis
Speaker: Vibha Chaswal, - Miami Cancer Institute, Miami -
08:00am - 09:00am PT
Comparative Survival Analysis of Dose Fractionation Regimens in Fractionated Stereotactic Radiotherapy (FSRT) for Brain Metastases
Speaker: Ran Yang, MD - Department of Radiation Oncology, The First Hospital of China Medical University, Shenyang -
08:00am - 09:00am PT
Comparison of Single Dose Radiation Therapy and Stereotactic Body Radiation Therapy in Patients with Spinal Metastases
Speaker: Brandon Cuevas, - Tri-Institutional MD-PhD Program, New York -
08:00am - 09:00am PT
Conventional Target Volume Delineation in Glioblastoma: Insights from a Large Multicenter Academic Practice
Speaker: David Crompton, MD, BS - Mayo Clinic College of Medicine and Science Jacksonville, Jacksonville -
08:00am - 09:00am PT
Cost-Effectiveness of Vorasidenib for Patients with Isocitrate Dehydrogenase (IDH) Mutated Low-Grade Glioma (LGG)
Speaker: Adam Kessel, MD - Mayo Clinic Rochester, Rochester -
08:00am - 09:00am PT
-
08:00am - 09:00am PT
Developing Highly Accessible Illustrated Guides for Radiation Consultation
Speaker: Shari Bodofsky, MD - Yale Therapeutic Radiology, New Haven -
08:00am - 09:00am PT
Differential Modulation of TGF-ß Family Members through Androgen Receptor Inhibition in Glioblastoma
Speaker: Jyoti Kaushal, PhD - University of Nebraska Medical Center, Omaha -
08:00am - 09:00am PT
Disparities in Radiation Treatment of Breast Cancer Brain Metastases
Speaker: Thamilini Pathmarajah, - University of Chicago, Honolulu -
08:00am - 09:00am PT
Does Pulsed Low-Dose Rate Radiotherapy Reduce the Dose to Circulating Lymphocytes in Glioblastoma?
Speaker: Bingqi Guo, PhD - Cleveland Clinic, Cleveland -
08:00am - 09:00am PT
Dose-Response Relationship in Single Fraction Stereotactic Radiosurgery for Local Control of Spinal Melanoma Metastases
Speaker: Jessica Bai, BS - Case Western Reserve School of Medicine, Cleveland -
08:00am - 09:00am PT
Early Initiation of Radiation Therapy Improves Survival in Elderly Patients with Glioblastoma
Speaker: Neil Almeida, MD - Roswell Park Comprehensive Cancer Center, Buffalo -
08:00am - 09:00am PT
Education Opportunities Presented by the Radiation Oncology Virtual Education Rotation
Speaker: Juliana Runnels, MD - Icahn School of Medicine at Mount Sinai, New York -
08:00am - 09:00am PT
Educational Pedigree and Residency Placement: The Impact of Private Education on Match Success
Speaker: Austin Williams, BS - Baylor College of Medicine, Houston -
08:00am - 09:00am PT
Enhancing Opportunities for Resident-Supervised Medical Student Research: A 7-Year Evaluation of the Oncology Research Internship (ORIoN)
Speaker: Vivian Tan, MD - London Health Sciences Centre, London -
08:00am - 09:00am PT
EQual Rubric Evaluation of the Radiation Oncology Education Collaborative Study Group Entrustable Professional Activities
Speaker: Brett Wagner, - Rush University Medical Center, Chicago -
08:00am - 09:00am PT
Esophagitis and Pharyngitis after Re-Irradiation Spine SBRT of 24Gy in 2 Fractions
Speaker: Kentaro Taguchi, MD - Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Ibaraki -
08:00am - 09:00am PT
Ethics-Guided Radiation Therapy (EGRT): Knowledge, Attitude, Practice (KAP) Global Survey
Speaker: Layth Mula-Hussain, MBChB, MSc, EF, FRCP Edin - Zhianawa Cancer Center, Sulaymaniyah -
08:00am - 09:00am PT
Evaluating Neurocognitive Improvement Following Stereotactic Radiosurgery and Whole Brain Radiation Therapy: A Pooled Analysis of Two Phase III Trials
Speaker: Reza Zarinshenas, MD - University of Maryland Radiation Oncology, Baltimore -
08:00am - 09:00am PT
Evaluating Neurologic Causes of Death in Melanoma Patients with Brain Metastasis Treated with SRS and Immunotherapy: A Retrospective Cohort Study
Speaker: Nga Nguyen, MD, MD, MPH - Wake Forest Baptist Medical Center, Winston Salem -
08:00am - 09:00am PT
Evaluating Outcomes of Patients Receiving SRS to More Than 15 Brain Metastases in a 12-Month Span
Speaker: John Hoyle, MD, MS - University of Alabama Birmingham School of Medicine, Birmingham -
08:00am - 09:00am PT
Evaluating Post-Radiation Effects in Meningioma and Glioma Patients: A Proton vs. Photon Therapy Comparison
Speaker: Aren Saini, BS - University of Miami Leonard M. Miller School of Medicine, Miami -
08:00am - 09:00am PT
Evaluating the Current Literature and Visibility of Anatomy Education in U.S. Radiation Oncology Residency Programs
Speaker: Amanda Acevedo, BS - University of Florida College of Medicine, Gainesville -
08:00am - 09:00am PT
Evolving Role of Virtual Education in Radiation Oncology: Insights from the ROVER Initiative
Speaker: Katelyn Ragland, MD - University of Alabama at Birmingham, Birmingham -
08:00am - 09:00am PT
Examining the Effects of Whole Brain Radiation Therapy and Stereotactic Radiosurgery on Brain Aging by Surface-Based Deep Learning
Speaker: Stephanie Zhao, BS - Washington University School of Medicine, Saint Louis -
08:00am - 09:00am PT
Exploring the Ef?cacy and Optimal Duration of Tumor Treating Fields (TTFields) in Newly Diagnosed Who Grade 4 Gliomas: A Multi-Institutional Analysis
Speaker: Guang Han, MD - Hubei Cancer Hospital, Wuhan -
08:00am - 09:00am PT
Extended Field Radiosurgery of Spinal Metastases with MRI-Guided Adaptive Planning: A Dosimetric Study
Speaker: David Lee, MD - University of Miami - Sylvester Cancer Center, Coral Gables -
08:00am - 09:00am PT
Financial Boon or Bust: Analyzing the Use of Crowdfunding for Radiation Therapy in the Treatment of Brain Tumors
Speaker: Lauren Formanski, - Rutgers Robert Wood Johnson Medical School, New Brunswick -
08:00am - 09:00am PT
From Burnout to Balance: Evaluating SimPOD Workload and Well-Being in a High-Volume Radiation Oncology Department
Speaker: Han Liu, MS - Mayo Clinic Rochester, Rochester -
08:00am - 09:00am PT
Genomic Signature to Predict Neurologic Death in Non-Small Cell Lung Cancer Patients
Speaker: Sarah Glynn, DO - Wake Forest Baptist Health, Winston-Salem -
08:00am - 09:00am PT
Glutamate and Glutamine (Glx) Measurements in High Grade Glioma in Response to Radiation Therapy: A Magnetic Resonance Spectroscopic Imaging Study at 3 T
Speaker: Atiyah Yahya, - Department of Medical Physics, Cross Cancer Institute, Edmonton -
08:00am - 09:00am PT
Gradient-Based Radiomics Analysis for Outcome Prediction in Personalized Ultra-Fractionated Stereotactic Adaptive Radiotherapy (PULSAR)
Speaker: Haozhao Zhang, MS - UT Southwestern Medical Center, Dallas -
08:00am - 09:00am PT
Histone-Altered Diffuse Midline Glioma (DMG): Clinic-Pathological Spectrums and Outcomes from a Large Specialized Neuro-Oncology Practice in India
Speaker: Meenakshi Jeeva, MD - Princess Margaret Cancer Center, University Health Network, Toronto -
08:00am - 09:00am PT
Identifying Clinical Determinants of Intrafraction Motion during Spine Stereotactic Body Radiotherapy
Speaker: Kara Banson, MD - NYU Langone Health- Radiation Oncology, New York -
08:00am - 09:00am PT
Immune Landscape of Radiation Necrosis vs Local Failure in Melanoma Brain Metastases Treated with Stereotactic Radiosurgery
Speaker: Maleeha Qazi, MD, PhD - University of Toronto, Toronto -
08:00am - 09:00am PT
-
08:00am - 09:00am PT
Impact of Fractionation and Tumor Size on Radiation Necrosis and Local Control in Patients with Non-Small Cell Lung Cancer Brain Metastases Treated with Stereotactic Radiosurgery and Concurrent Immuno
Speaker: Jacob Oyeniyi, MD - Corewell Health William Beaumont University Hospital, Royal Oak -
08:00am - 09:00am PT
Impact of Pain Management Interventions and Radiation Therapy on Pain Control and Treatment Accuracy in Spine Radiation for Metastasis
Speaker: Sybil Sha, MD - Memorial Sloan Kettering Cancer Center, New York -
08:00am - 09:00am PT
Impact of Radiation Therapy Fractionation on Survival Outcomes in Elderly Patients with Glioblastoma Following Surgical Resection and Adjuvant Chemotherapy
Speaker: Jonathon Cummock, BS - Texas A&M College of Medicine, Bryan -
08:00am - 09:00am PT
Impact of Thoracic Radiotherapy on Survival Outcomes in Extensive-Stage Small Cell Lung Cancer with Brain Metastases: A Multicenter Retrospective Study
Speaker: Butuo Li, MD, MB, PhD - Shandong Cancer Hospital Affiliated to Shandong First Medical University, Jinan -
08:00am - 09:00am PT
Impact of Time from MRI on Local Control for Fractionated Single Isocenter Zero Margin Radiosurgery for Brain Metastases
Speaker: Luke Moradi, MD - University of Alabama at Birmingham, Birmingham -
08:00am - 09:00am PT
Impact of Upfront vs. Salvage Radiation in Low Grade Glioma
Speaker: Yuhao Shi, MD, PhD - NYU Langone Health- Radiation Oncology, New York -
08:00am - 09:00am PT
Improving Glioblastoma Radiotherapy Target Delineation via a Diffusion Model
Speaker: Wan-Jin Yeo, PhD - University of California, San Francisco, San Francisco -
08:00am - 09:00am PT
Incidence of Radiation Necrosis with Immunotherapy in the Management of Brain Metastasis: A Systematic Review and Meta-Analysis
Speaker: Marielle Fis Loperena, BS - GW Medical School, Washington -
08:00am - 09:00am PT
Integrated Multiparametric Magnetic Resonance Imaging and Co-Registered Macropathology for Physiological Tumor Habitat Identification and Personalized Clinical Target Volume Determination in Glioma
Speaker: Shulun Nie, MD - Shandong Cancer Hospital and Institute affiliated to Shandong University, Jinan -
08:00am - 09:00am PT
Integrating Collagen Tile Brachytherapy with External Beam Radiation and Temozolomide for Newly Diagnosed Glioblastoma: A Preliminary Report from a Feasibility Trial
Speaker: Matthew Peach, MD, MB, PhD - UVA School of Medicine, Charlottesville -
08:00am - 09:00am PT
International Multidisciplinary Delphi Consensus to Align Definitions, Reporting Items and Study Endpoints for Future Clinical Trials and Audits on Malignant Spinal Cord Compression
Speaker: Henry Wong, MBBS - Princess Margaret Hospital Hong Kong, Hong Kong -
08:00am - 09:00am PT
Interplay of Monocytes and Lymphocytes during Radiation for Glioblastoma Impacts Patient Survival
Speaker: Samuel Workman, MD - Johns Hopkins Hospital, Baltimore -
08:00am - 09:00am PT
Intracranial Progression Following Hippocampal-Avoiding Whole Brain Radiotherapy in Patients with Brain Metastasis
Speaker: Emre Guvenli, MD - University of North Carolina, Chapel Hill -
08:00am - 09:00am PT
Long-Term Outcomes Following Radiation Therapy for Optic Nerve Sheath Meningioma: A Single-Center Experience
Speaker: Tugba Yilmaz, MD - Mass General Brigham/Massachusetts General Hospital/Harvard Med School, Boston -
08:00am - 09:00am PT
Long-Term Outcomes in IDH-Wildtype Gliomas with Historical WHO Grade 2 and 3 Histology
Speaker: Patrick Carriere, MD, PhD - MD Anderson Cancer Center, Houston -
08:00am - 09:00am PT
Long-Term Safety and Efficacy of SRS for Nonmalignant CNS Indications in Children and Young Adults
Speaker: Emily Smith, MD, BS - Stanford Health Care, Stanford -
08:00am - 09:00am PT
Machine Learning Model Based on Whole Brain Radioms to Identify High Risk of Short-Term Intracranial Progression after SBRT for Brain Metastases
Speaker: Qi Wang, MD, PhD, RT - Tianjin Medical University Cancer Hospital & Institute, Tianjin -
08:00am - 09:00am PT
Memory Circuit Dosimetry in Patients Treated with SRS for Brain Metastases
Speaker: Nina Lo, MS - UPMC Hillman Cancer Center, Pittsburgh -
08:00am - 09:00am PT
Monitoring Glioblastoma Dynamics during Chemoradiation on the 1.5T Magnetic Resonance Imaging-Linear Accelerator
Speaker: Kurl Jamora, MD - Philippine General Hospital, Manila -
08:00am - 09:00am PT
MR-Guided Adaptive Radiotherapy for Glioblastoma: Clinical Outcomes and Quality of Life in an Australian Cohort
Speaker: Kurl Jamora, MD - Philippine General Hospital, Manila -
08:00am - 09:00am PT
Nascent Clinical Experience with Radiotherapeutic Management of Melanoma Brain Metastases in Patients Treated with Tumor-Infiltrating Lymphocyte (TIL) Therapy
Speaker: Abrar Choudhury, MD, PhD - Mass General Brigham/Massachusetts General Hospital/Harvard Med School, Boston -
08:00am - 09:00am PT
National Trends on Use of Radiotherapy for Elderly Patients with Glioblastoma: A National Cancer Data Base Study
Speaker: Rimsha Afzal, BS - Kentucky College of Osteopathic Medicine, Pikeville -
08:00am - 09:00am PT
Neurocognition Following Repeated Stereotactic Radiosurgery for 1-10 Brain Metastases: Results of the CYBER-SPACE Randomized Phase II Trial
Speaker: Rami El Shafie, MD - University Medical Center Gottingen (UMG), Göttingen -
08:00am - 09:00am PT
Normal Tissue Complication Probability Model Predicting the Risk of Radiation Necrosis after Stereotactic Radiosurgery for Small Brain Metastases
Speaker: Sreenija Yarlagadda, MD - Miami Cancer Institute, Miami -
08:00am - 09:00am PT
Novel Volume Staged Stereotactic Radiosurgery (VS-SRS) for the Treatment of Large Volume Cerebral Arteriovenous Malformation (AVM)
Speaker: Ramesh Gadam, MD, MBBS - University of Kansas Medical Center, Kansas City -
08:00am - 09:00am PT
Outcomes Associated with Proton Spine Stereotactic Body Radiation Therapy
Speaker: Christopher Jackson, MD, MS - Memorial Sloan Kettering Cancer Center, New York -
08:00am - 09:00am PT
Outcomes for Patients with High-Risk IDH-Mutant Grade 2 Gliomas Treated with IDH Inhibitors
Speaker: Jane Pearce, MD - MD Anderson Cancer Center, Houston -
08:00am - 09:00am PT
Outcomes of Radiation Oncology Residents Participating in the American Board of Radiology Holman Pathway Program
Speaker: Joanna Yang, MD, MPH - Washington University in St Louis, St Louis -
08:00am - 09:00am PT
Pattern of Recurrence with 1.0cm CTV in Glioblastoma Treated with Concurrent Radiotherapy and Temozolomide
Speaker: Erica Braschi, MD - Department of Radiation Oncology, University of Florida College of Medicine, Jacksonville -
08:00am - 09:00am PT
Photon-Based Stereotactic Radiosurgery-Style Planning for the Treatment of Primary Brain Tumors to Reduce Radiation Dose to the Uninvolved Brain
Speaker: Joseph Shields, MS - Department of Radiation Oncology, UPMC Hillman Cancer Center, Pittsburgh -
08:00am - 09:00am PT
Planning Assessment of Pre-RT White Matter Mapping-Enhanced CTV for Glioblastoma Radiation Therapy
Speaker: Evan Porter, PhD - University of California San Francisco, San Francisco -
08:00am - 09:00am PT
Predicted vs. Observed Survival of Patients Undergoing Surgical Resection for Brain Metastases
Speaker: Jeffrey Quezada, BS - University of California Irvine School of Medicine, Irvine -
08:00am - 09:00am PT
Predicting the Region of Tumor Microinfiltration within the Peritumoral Edema of Glioblastoma Using a Multiparametric Magnetic Resonance Model
Speaker: Jinling Zhang, - Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Linyi -
08:00am - 09:00am PT
Predictive Factors for Survival after Reirradiation of IDH Mutant High-Grade Glioma
Speaker: John Petersen, DO - Wake Forest Baptist Medical Center, Winston Salem -
08:00am - 09:00am PT
Preoperative Radiosurgical Boost in Newly Diagnosed Glioblastoma
Speaker: Daniel Trifiletti, MD - Mayo Clinic, Jacksonville -
08:00am - 09:00am PT
Pre-Treatment Vascular Profiling on Multiparametric MRI for Improved Radiation Necrosis Prediction after Brain SRS
Speaker: Yi Lao, PhD - University of California Los Angeles, Los Angeles -
08:00am - 09:00am PT
Progression-Free Survival in Grade 2-3 Meningiomas: A Retrospective Analysis of Surgical and Radiotherapy Treatment Approaches at One Institution
Speaker: Fereshteh Talebi, - Weill Cornell Medical College, New York -
08:00am - 09:00am PT
Proton Craniospinal Radiation for Leptomeningeal Disease from Patients with Metastatic Solid Tumors: A Multi-Institutional Retrospective Analysis
Speaker: Matthew Riina, MD - Hospital of the University of Pennsylvania, Philadelphia -
08:00am - 09:00am PT
Proton vs. VMAT-Based Craniospinal Irradiation for Leptomeningeal Carcinomatosis: An Institutional Dosimetric and Hematologic Toxicity Analysis
Speaker: Richard Ngo, MD - University of Utah, Salt Lake City -
08:00am - 09:00am PT
Radiation Necrosis Management and Outcome in Patients with NSCLC Brain Metastases Treated with SRS in the Era of Immunotherapy
Speaker: Sunitha Varghese, MD, MBBS - The University of Kansas Health System, Kansas city -
08:00am - 09:00am PT
-
08:00am - 09:00am PT
Radiation Oncology Physician Portrayals: Characterizing Online Representations of NCCN Member Institutions
Speaker: John Byun, MD - Department of Radiation Oncology, Stanford University, Stanford -
08:00am - 09:00am PT
Radiation-Induced <em>HMGB2 </em>Cytoplasmic Translocation Associates with Enhanced Immune Response Pathways in Glioma
Speaker: Aline Becker, MD, PhD, MS - The Ohio State University, Columbus -
08:00am - 09:00am PT
Radiologic and Clinical Outcomes of Frameless Gamma Knife Stereotactic Radiosurgery for Vestibular Schwannomas
Speaker: Kayla Daniell, MD, BS - Columbia and Cornell University, New York -
08:00am - 09:00am PT
Radiomic Substudy of a Phase 1b Trial of MW151 for Cognitive Impairment after Hippocampal Avoidant Whole Brain Radiotherapy (HA-WBRT) for Intracranial Metastases
Speaker: Qian Zhang, MD, PhD, MS - McGaw Medical Center of Northwestern University, Chicago -
08:00am - 09:00am PT
Radiomics-Clinical Integration Guides Prophylactic Cranial Irradiation Decisions in Limited-Stage Small Cell Lung Cancer: A Brain Metastasis Risk Stratification Model
Speaker: Yuntao Zhou, - Tianjin Medical University Cancer Institute & Hospital, Tianjin -
08:00am - 09:00am PT
RadOnc Smart Learn: An AI-Powered Platform for Longitudinal, Personalized Oral Board Preparation in Radiation Oncology
Speaker: Abass Conteh, MD, PhD - Stanford Healthcare, Palo Alto -
08:00am - 09:00am PT
Real-World Use of Nivolumab plus Relatlimab in the Multi-Modal Management of Melanoma Brain Metastases
Speaker: Vaseem Khatri, MD - Moffitt Cancer Center, Tampa -
08:00am - 09:00am PT
Re-Irradiation with Three-Fraction Stereotactic Body Radiation Therapy for Spinal Metastases
Speaker: Christopher Jackson, MD, MS - Memorial Sloan Kettering Cancer Center, New York -
08:00am - 09:00am PT
Repeat Stereotactic Body Radiotherapy (SBRT) for Spinal Metastases: Local Control and Toxicity
Speaker: Samuel Adida, MS - University of Pittsburgh Department of Neurological Surgery, Pittsburgh -
08:00am - 09:00am PT
Repeat Stereotactic Radiosurgery for Recurrent Brain Metastases: A Retrospective Comparison of Local Progression and Distant Brain Metastases after Prior Radiosurgery
Speaker: Masamune Noguchi, MD - Aichi Cancer Center Hospital, Nagoya -
08:00am - 09:00am PT
Research Productivity among Applicants to an ACGME-Accredited U.S. Radiation Oncology Residency Program: 2015 to 2024
Speaker: Kristin Hsieh, MD - Icahn School of Medicine at Mount Sinai, New York -
08:00am - 09:00am PT
Resident Perceptions of Bias in Competency Assessment in U.S. Radiation Oncology Programs
Speaker: Dasha Klebaner, MD, BS, MPH - Stanford University Cancer Center, La Jolla -
08:00am - 09:00am PT
Risk of Secondary Malignancy after Radiotherapy for Benign Intracranial Tumors
Speaker: Huzaifah Mahmood, MD - New York Presbyterian Hospital Columbia Campus, New York -
08:00am - 09:00am PT
Safety Analysis of a Prospective Phase 2 Trial of Hypofractionated Proton Therapy for Benign Intracranial Tumors
Speaker: Nicholas Bader, MD - Emory University School of Medicine, Atlanta -
08:00am - 09:00am PT
Safety and Feasibility of Simultaneous Integrated Tumor Boost with Hippocampal-Avoidance Whole Brain Radiotherapy for Patients with Brain Metastases
Speaker: Soumil Jain, - The Ohio State University College of Medicine, Columbus -
08:00am - 09:00am PT
Salvage Fractionated Stereotactic Spine Radiosurgery for Recurrent Metastatic Renal Cell Carcinoma
Speaker: Forrest Kwong, MD - MD Anderson Cancer Center, Houston -
08:00am - 09:00am PT
Salvage Stereotactic Radiation for Recurrent or Progressive Metastatic Spine Disease after Initial Stereotactic Radiation
Speaker: Ahmed Elguindy, MD - James Cancer Hospital-Solove Research Institute, Columbus -
08:00am - 09:00am PT
Shifting characteristics of medical students applying to Radiation Oncology residency
Speaker: Celeste Hsu, MBE - UCSD School of Medicine, -
08:00am - 09:00am PT
Signals in the Shadows : Structural Imaging and Electrophysiological Insights in Optic Nerve Schwannoma Adjuvant Therapy
Speaker: Vangipuram Shankar, MD, MBBS - C r reddy superspeciality hospital, Nellore -
08:00am - 09:00am PT
Stereotactic Body Radiation Therapy for Radioresistant Lumbosacral Spine Metastases: Clinical Outcomes and Predictors of Local Control
Speaker: Yen-Ruh Wuu, MD - Northwell Health, Lake Success -
08:00am - 09:00am PT
Stereotactic body radiotherapy (SBRT) boost following urgent 3D conformal radiotherapy in the treatment of metastatic epidural spinal cord compression (MESCC): A phase I feasibility trial
Speaker: Elysia Donovan, MD, MS - Sunnybrook Odette Cancer Center, Toronto -
08:00am - 09:00am PT
Stereotactic Radiosurgery for 15 or more Brain Metastases is Safe and Effective
Speaker: Tina Vaziri, MD, BS - Johns Hopkins Hospital, Baltimore -
08:00am - 09:00am PT
Stereotactic Radiosurgery for Myxomatous Oncotic Cerebral Aneurysms: A Case Series
Speaker: Nicolas Nelson, MD - University of California, Los Angeles (UCLA), Los Angeles -
08:00am - 09:00am PT
Stereotactic Radiosurgery (SRS) over Whole Brain Radiotherapy (WBRT) Preserves Brain Volume: An Imaging and Radiomic Analysis
Speaker: Joseph Bae, MS, BS - Stony Brook University, Stony Brook -
08:00am - 09:00am PT
Stereotactic Radiotherapy for intracranial and intramedullary hemangioblastomas.
Speaker: Andrey Golanov, MD, PhD - Burdenko Neurosurgical Institute, Moscow -
08:00am - 09:00am PT
Survey based assessment of quality of Resident education in Radiation Oncology in United States.
Speaker: Kirti Sharma, - Virginia Commonwealth University, Richmond -
08:00am - 09:00am PT
Survey on Education of Systemic Therapy (Immunotherapy, Targeted Therapy, Chemotherapy) During Radiation Oncology Residency
Speaker: Oluwatimileyin Ojo, MD - Northwell Health, Lake Success -
08:00am - 09:00am PT
Survival and CNS Disease Control Among Patients with HER2 Low Versus HER2 High Metastatic Breast Cancer with Brain Metastases Treated with SRS
Speaker: Ian Messing, MD - The Hospital of the University of Pennsylvania, Philadelphia -
08:00am - 09:00am PT
Survival Impact of Histological vs. Molecular Glioblastoma: A Propensity Score-Matched Analysis
Speaker: Nikunj Patil, MD, MBBS - Kasturba Medical College, Manipal -
08:00am - 09:00am PT
Temporal Lobe Radionecrosis after Proton Beam Radiation in Patients with Skull Base Chordoma
Speaker: Hamid Mammar, PhD, MD - Institut Curie, PALAISEAU -
08:00am - 09:00am PT
The Association of Linear Energy Transfer and Dose with Late Radiation-Induced Contrast-Enhancement after Proton Therapy in CNS Malignancy
Speaker: Ellen Huang, PhD - Johns Hopkins Radiation Oncology Kimmel Cancer Center, Harrisburg -
08:00am - 09:00am PT
The Hearing Preservation in Patients with Schwannomatosis after Combined Treatment
Speaker: Elizaveta Makashova, MD - Burdenko Neurosurgical Institute, Moscow -
08:00am - 09:00am PT
The Impact of a Multidisciplinary Oncology Panel on Medical Student Perceptions of Radiation Oncology
Speaker: Andrew Hoover, MD - University of Kansas Medical Center, Kansas City -
08:00am - 09:00am PT
The Impact of Image Guidance on Hippocampal Dose in Hippocampal Avoidance Whole Brain Radiotherapy - A Secondary Analysis of a Randomized Clinical Trial
Speaker: Wen-Chi Yang, MD - National Taiwan University Hospital, Taipei -
08:00am - 09:00am PT
The Role of Radiotherapy in Resected Non-Small Cell Lung Cancer Brain Metastases Treated with CNS-Active Tyrosine Kinase Inhibitors
Speaker: Abrar Choudhury, MD, PhD - Mass General Brigham/Massachusetts General Hospital/Harvard Med School, Boston -
08:00am - 09:00am PT
The State of Wellness Curricula in Radiation Oncology Residency Programs: Current Landscape and Future Directions
Speaker: Emily Boyer, MD - University of Ottawa, Ottawa -
08:00am - 09:00am PT
The Use of Tumor Treating Fields Therapy for Newly Diagnosed Glioblastoma in Elderly Populations: A Single-Institution Study
Speaker: Chase Owens, BS - UTHSC College of Medicine, Memphis -
08:00am - 09:00am PT
Radiation Therapy Effects on Spectroscopic MRI Metabolites in Recurrent Glioblastoma
Speaker: Abram Abdou, - University of Miami, Miami -
08:00am - 09:00am PT
Toxicity Comparison of Photon and Proton Craniospinal Irradiation for Leptomeningeal Carcinomatosis
Speaker: Isabella Dreyfuss, DO - University of Miami, Miami -
08:00am - 09:00am PT
TRIB1 Modulates p53 Pathway in GBM Cells via HDAC1 in Response to Radiation Treatment
Speaker: Karnika Singh, PhD, MBA - OSU CCC, Columbus -
08:00am - 09:00am PT
Tumor Dynamics and Dosimetric Impact during Multi-Day Adaptive Stereotactic Radiosurgery (SRS) for Multiple Brain Metastases
Speaker: Ibrahim Durowoju, - University of Toronto, Toronto -
08:00am - 09:00am PT
Use of a Foundation Medical Imaging Model to Improve the Performance for Automated Brain Metastasis Segmentation
Speaker: Yiding Han, - Baylor College of Medicine, Houston -
08:00am - 09:00am PT
User Experience with Artificial Intelligence-Generated Research Education Podcast Series
Speaker: John Peterson, MD - H. Lee Moffitt Cancer Center and Research Institute, Tampa -
08:00am - 09:00am PT
Virtual Medical Student Education in a Post-Pandemic World: Lessons from a Multi-Institutional Virtual Radiation Oncology Clerkship
Speaker: Adam Eakin, MD - Oregon Health and Science University, Portland -
08:00am - 09:00am PT
Volumetric Modulated Arc Therapy Integrating Static Angle Modulated Ports and Dynamic Collimator Rotation Improves Dosimetry and Efficiency of Stereotactic Radiosurgery for Spine Metastasis
Speaker: Shu-Fan Wang, MS - Department of Radiation Oncology, National Taiwan University Cancer Center, Taipei